Clinical Trials Logo

Sleep Bruxism clinical trials

View clinical trials related to Sleep Bruxism.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06259786 Completed - Nocturnal Bruxism Clinical Trials

Investigation of Adolescents With Nocturnal Bruxism

Start date: February 1, 2024
Phase:
Study type: Observational

The aim of this study is to examine the effects of bruxism on mandibular movement capacity, cervical proprioception, posture and quality of life in adolescents diagnosed with nocturnal bruxism (clenching and grinding teeth while sleeping) between the ages of 13-18 and to compare them with healthy adolescents. Method: A total of 40 adolescents, 20 with nocturnal bruxism and 20 healthy, will be included in the study. Mandibular movement capacity will be evaluated with a caliper and ruler, cervical proprioception with a CROM device, posture with the New York Posture Scale, and quality of life with the PedsQL 13-18 age scale. Hypotheses: H1: Nocturnal bruxism reduces the movement capacity of the mandible in adolescents. H2: Nocturnal bruxism reduces cervical proprioception in adolescents. H3: Posture disorder increases in adolescents with nocturnal bruxism. H4: Nocturnal bruxism affects the level of daily life quality in adolescents.

NCT ID: NCT06232993 Completed - Bruxism Clinical Trials

Management of Myofascial Pain in Children With Sleep Bruxism

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

This study compared the effectiveness of Kinesio tape and occlusal splint application in improving sleep quality and reducing myofascial pain in children with sleep bruxism.

NCT ID: NCT05620316 Completed - Nocturnal Bruxism Clinical Trials

The Use of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle to Treat Sleep Bruxism

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

Botulinum toxin (BOTOX®) injections into the masseter muscle are an effective treatment for nocturnal bruxism, with several trials using various dosages of botulinum toxin for this purpose. The aim was to evaluate the effectiveness of injecting 10MU of botulinum toxin A (BTXA) into the masseter muscle to reduce nocturnal bruxism, the sample will randomly divided into 2 groups. In the injection group, Patients will inject with 10 MU of botulinum toxin type A (BOTOX® - Allergan Inc. - Dublin - Ireland) per side at two sites into the masseter muscle bilaterally. In this Placebo group, patients will prick twice at the inferior prominent part of the masseter muscle observed using the stinger pen used in the blood glucose meter. The evaluation will make by Electromyography (EMG) analysis, Visual Analogue Scale (VAS) values.

NCT ID: NCT05323942 Completed - Clinical trials for Sleep Bruxism, Childhood

The Effect of Sleep Hygiene and Exercise Therapy in Children With Sleep Bruxism

Start date: March 8, 2020
Phase: N/A
Study type: Interventional

The aims of this study were to determine the relationship between sleep bruxism, oral habits, and sleep habits and establish treatment approaches in children.

NCT ID: NCT04934449 Completed - Sleep Clinical Trials

Occlusal Splints in the Treatment of Sleep Bruxism

bruxism
Start date: August 6, 2021
Phase: N/A
Study type: Interventional

Occlusal splints are employed in the treatment of sleep bruxism. These appliances decrease sleep-related actions and damages bruxism, like grinding, tooth-wear, headache, and temporomandibular joint disorders. Occlusal splints are produced both in hard and soft forms according to the used material. In this study, it was aimed to evaluate the effect of occlusal splint type on the sleep quality and occlusal force parameters of patients with sleep bruxism.

NCT ID: NCT04842136 Completed - Headache Clinical Trials

Factors Affecting Patients With Myofascial Temporomandibular Disorders

Start date: January 13, 2020
Phase:
Study type: Observational

The aim of the study was to assess and compare the relationship between jaw function, neck disability, sleep quality, fatigue, and headache in patients with myofascial Temporomandibular Disorder (TMD) with Sleep Bruxism (SB) and without (non-SB).

NCT ID: NCT04015349 Completed - Clinical trials for Sleep Bruxism, Adult

Clinical Condition and Sleep Quality Factors Associated With Sleep Bruxism in Adults.

Start date: July 1, 2017
Phase:
Study type: Observational

This cross-sectional study will evaluate the association between sociodemographic, occupational, clinical conditions, psychological (sense of coherence), sleep quality variables and SB diagnosed by PSG, the gold standard exam with audio-visual resources obtained at Pelotas Sleep Institute.

NCT ID: NCT03833505 Completed - Bruxism, Sleep Clinical Trials

Enterobius Vermicularis and Bruxism in Children

Start date: March 15, 2017
Phase:
Study type: Observational

Background. Bruxism is an involuntary, non-functional activity of the masticatory system, and is frequently seen in childhood. Bruxism has many aetiologies, like malocclusion, psychological factors, allergies and gastrointestinal disorders. Aim. To investigate the relationship between Enterobius vermicularis infection and bruxism in children.

NCT ID: NCT03825237 Completed - Clinical trials for Sleep Bruxism, Adult

Sleep Architecture and Factors Associated With Definitive Diagnosis of Sleep Bruxism

Start date: January 1, 2018
Phase:
Study type: Observational

This case-control study will evaluates the association between the definitive sleep bruxism diagnosis by gold-standard polysomnography examination obtained at Pelotas Sleep Institute and the sociodemographic, occupational, clinical conditions, sleep quality, sleep structure and Epworth sleepiness scale variables.

NCT ID: NCT03810248 Completed - Clinical trials for Obstructive Sleep Apnea

Association Between Obstructive Sleep Apnea and Bruxism

Start date: July 17, 2019
Phase:
Study type: Observational

The objective of this retrospective observational study will be to investigate the between the Obstructive Sleep Apnea Syndrome (OSAS) and Sleep Bruxism (SB), in individuals diagnosed through polysomnography (PSG).